EAN 2026 | Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features

Alicja Kalinowska, MD, PhD, Poznań University of Medical Sciences, Poznań, Poland, shares insights into diagnosing multiple sclerosis (MS) in patients with prodromal signs, highlighting the importance of objectifying patient complaints and using MRI biomarkers to distinguish MS on biological grounds. Prof. Kalinowska notes that early signs of MS can be detected through measures such as the modified fatigue impact scale, urinary bladder diary, and cognitive tests, allowing for earlier diagnosis and attribution of symptoms to MS. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.